البلد: كندا
اللغة: الإنجليزية
المصدر: Health Canada
AMPICILLIN (AMPICILLIN SODIUM)
FRESENIUS KABI CANADA LTD
J01CA01
AMPICILLIN
250MG
POWDER FOR SOLUTION
AMPICILLIN (AMPICILLIN SODIUM) 250MG
INTRAMUSCULAR
10 ML
Prescription
AMINOPENICILLINS
Active ingredient group (AIG) number: 0105872002; AHFS:
APPROVED
1998-01-06
_____________________________________________________________________________________________ Ampicillin for Injection, USP_ _– Prescribing Information Page 1 of 10 PRESCRIBING INFORMATION INCLUDING PATIENT MEDICATION INFORMATION PR AMPICILLIN FOR INJECTION, USP Powder for solution 250 mg, 500 mg, 1 g and 2 g per vial For Intramuscular or Intravenous Use STERILE ANTIBIOTIC FRESENIUS KABI CANADA LTD. Date of Preparation: 165 Galaxy Blvd, Suite 100 August 16, 2019 Toronto, ON M9W 0C8 CONTROL NUMBER: 223388 _____________________________________________________________________________________________ Ampicillin for Injection, USP_ _– Prescribing Information Page 2 of 10 PRESCRIBING INFORMATION PR AMPICILLIN FOR INJECTION, USP Powder for solution Sterile PHARMACOLOGICAL CLASSIFICATION Antibiotic ACTIONS AND CLINICAL PHARMACOLOGY Ampicillin has a broad spectrum of bactericidal activity against many gram-positive and gram- negative aerobic and anaerobic bacteria. It acts through the inhibition of cell wall mucopeptide biosynthesis during the stage of active multiplication. INDICATIONS AND CLINICAL USE The treatment of infections due to susceptible gram-negative organisms (including strains of _Shigellae_, _ S. typhosa_ and other _salmonellae, E. coli_, _ H. influenzae_, and _ P. mirabilis_) and susceptible gram-positive organisms [including streptococci, pneumococci, and non-beta- lactamase (penicillinase) producing staphylococci]. To reduce the development of drug ‐ resistant bacteria and maintain the effectiveness of Ampicillin for Injection, USP and other antibacterial drugs, Ampicillin for Injection, USP should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. CONTRAINDICATIONS A history of alle اقرأ الوثيقة كاملة